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Tvic-hosporon bekelii, a yeast found in stagnant and fresh 
water, is known to cause superficial skin infections. It 
may be part of the normal human skin and respiratory 
tract flora. 7: bripl i i  has emerged in recent years as 
an opportunistic pathogen for iinniunocoiiipromised 
hosts. It is capable of causing either invasive disease in 
a single organ site or disseminated disease [I-61. It may 
cause outbreaks of serious infection in neonatal intensive 
care units, especially aniong premature infants 161. 
The most likely primary source of the infection is the 
patient’s own gastrointestinal and respiratory flora; the 
gastrointestinal and respiratory tracts have been shown 
to be the sites of fungal colonization in hospitalized 
patients [7]. 
Continuous ambulatory peritoneal dialysis (CAPD) 
is a feasible alternative to hemodialysis. It has the 
advantage of allowing mobility, thus improving the 
quality of the patient’s life. However, peritonitis remains 
a serious problem for these patients and prompt diag- 
nosis and treatment are extremely important. More 
than 100 cases of disseminated trichosporonosis have 
been reported in the literature [3],  but only a few cases 
of 7: bekelii peritonitis have been reported [ 8 ] .  Recent 
exposure to antibiotics appears to be the most i n -  
portant risk factor [I]. We report here a case of 7: 
bekelii peritonitis in a 4-year-old male on CAPLI. 
The child reached the final stage of renal disease at  
the age of 11 months. He was treated with CAPD in 
the Division of Nephrology of f! and A. Kyriakou 
Children’s Hospital, and presented with peritonitis 
caused by Stapaphyloco~cus auwus at the age of 4 years 
(March 1994). The patient was treated successfully 
with intraperitoneal vancomycin and aniikacin without 
removal of the Tenckhoff catheter. In Lkceniber 1994 
he was admitted to the hospital with mild abdominal 
pain and a temperature of 38-3Y°C. The cell count 
in the peritoneal fluid was 900 white blood cells 
(\xJBC)/pL, with 98% neutrophils. In the Gram-stained 
preparation of the fluid’s sediment, only rare blasto- 
spores were seen. Treatment was started with flucyto- 
sine 500 mg/24 h intravenously and fluconazole 75 nig 
in every 2 L of dialysate. 
Twenty milliliters of peritoneal fluid was centri- 
fuged at 2500 rev/min for 10 min, to improve the 
sensitivity of the culture. 7: beiyelii grew promptly, 
in 24 h, both a t  room temperature and a t  37OC on 
Sabouraud’s dextrose agar. The yeast was identified by 
colony morphology, the presence of arthroconidia, 
blastoconidia, hyphae and pseudohyphae, the ability to 
assimilate sugars as demonstrated by AI’I 20 C (bio 
Mkrieux) and Auxacolor (microplate, Sanofi I h g -  
nostics Pasteur), the ability to produce urease, and the 
failure to produce germ tubes 19,101. By disk diffusion 
and by E-test [11,12], the fungus was sensitive to 
aniphotericin B, fluconazole and ketoconazole, and 
resistant to flucytosine. Flucytosine was replaced with 
aniphotericin B, starting with a dose of 0.1 mg/ 
kg/24 h and gradually increasing to 0.7 mg/kg/24 h. 
In spite of the appropriate antifungal treatment, 
the patient continued to have abdominal pain and 
turbid peritoneal fluid for 2 weeks. During this period, 
10 samples of peritoneal fluid were examined and 
cultured. WBC count ranged from 9OO/pL to 
2000/pL. ‘K bekelii was isolated from all peritoneal fluid 
specimens. O n  the 14th day of antifungal treatment, the 
Tenckhoff catheter was surgically removed and replaced 
with a new one. The tip of the removed catheter was 
cultured and 7: beijylii was the only species isolated. 
One week after the replacement of the catheter, the 
peritoneal fluid became clear. The WBC count was 
17/pL and the child was afebrile and free from 
abdominal pain. In February 1995, the child was 
discharged from the hospital. Amphotericin B had been 
administered for 26 days and fluconazole for 2 months. 
Cultures obtained from each peritoneal dialysis for 
6 months after completion of antifungal therapy were 
negative. 
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It has been shown that the azoles may have a 
role in the treatment of mycoses caused by 7: bekelii 
as an alternative to amphotericin B, particularly since 
7: be@& may sometimes be resistant to amphotericin 
B (131. In this case, in spite of the combined adniini- 
stration of amphotericin I3 and fluconazole, removal of 
the catheter was crucial. There is accumulating evidence 
that early removal of the catheter is important in 
treating fungal peritonitis [l], and most authorities 
recommend it at the beginning of therapy [14,15]. 
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